Brittany K. Bradrick

Director at Spectrum Pharmaceuticals

Brittany K. Bradrick is currently the Chief Financial Officer at Neurelis, Inc., a commercial stage neuroscience company. She has 25 years of experience in finance, strategy, and corporate development for life science companies, with both operational and advisory experience. Prior to joining Neurelis, Ms. Bradrick was Chief Operating Officer and Chief Financial Officer at ViaCyte. She previously served in strategy and corporate development positions for 10 years at Insulet Corporation as Vice President, Strategy & Corporate Development and at Abbott Diabetes Care as the Head of Global Business Development. Prior to these positions, Ms. Bradrick was an investment banker for the life sciences sector at Piper Jaffray, Credit Suisse, and Chase Securities for 10 years. Ms. Bradrick began her career as a Federal Reserve Bank Examiner.

Ms. Bradrick holds an MBA from the Johnson Graduate School of Management at Cornell University and a B.S. in Business Administration from the University of Missouri.

Timeline

  • Director

    Current role